EquityZen Growth Technology Fund LLC - Series 1762
Raised
$195K
Investors
14
Min Invest
$10,019
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1762 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett, raising $195K from 14 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1) exemptions. This is part of the EquityZen platform, which operates 1,889 related entities focused on pre-IPO secondary market access.
This pre-IPO fund uses the standard 506(b)/3(c)(1) exemption pairing typical of private equity pooled vehicles limited to fewer than 100 beneficial owners. The $10K minimum investment represents the accessible tier of EquityZen's platform model, designed to democratize pre-IPO exposure with relatively low entry points compared to institutional-only offerings.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
AltStreet Coverage
Original reporting from AltStreet's daily EDGAR monitoring covering EquityZen and its filings.
Nineteen EquityZen Series Report $10.5 Million Sold, Without Naming Underlying Companies
Nineteen series of EquityZen Growth Technology Fund LLC filed first Form D notices between September 22 and October 9, 2026, each reporting its full offering amount sold at filing, $10.5 million in total across 518 investor slots. None names the company whose shares it holds.
Platform coverage · Oct 2026
EquityZen Registered 16 New Pre-IPO SPVs in August, Five of Them in the Final Week
AltStreet's EDGAR monitoring counted 16 new EquityZen Growth Technology Fund series registered during August 2026, roughly four vehicles a week in the platform's first year under Morgan Stanley, with five filed between August 24 and 28 alone.
Platform coverage · Aug 2026
EquityZen Quietly Launches a Sixth Fund Family as Its SEC-Filed Census Passes $1.5 Billion
A first Form D from EquityZen Growth Access Fund LLC ($10.39 million across 51 investors, filed under the qualified-purchaser exclusion) and the largest Growth Technology Fund II series ever filed arrived within three weeks of each other. Seven months after the Morgan Stanley acquisition, no Morgan Stanley entity has appeared on any EquityZen Form D.
Platform coverage · Aug 2026
EquityZen Fund XI Series 2 Reaches $6.2M, 143 Investors After Minimum Falls to $5K
A June Form D/A shows EquityZen Growth Opportunity Fund XI Series 2 more than doubled reported capital to $6.2 million and nearly tripled its investor count from February. An earlier amendment filed one week after Morgan Stanley closed its EquityZen acquisition had reduced the vehicle's minimum accepted investment from $20,000 to $5,000.
Platform coverage · Jul 2026
EquityZen Fund XI Series 1 Investor Count Rises to 51, Up 82% From February
A June 5 Form D/A for EquityZen Growth Opportunity Fund XI Series 1 reports 51 investors, up from 28 in February and 16 when the vehicle launched in late 2025. The filing follows Morgan Stanley's January acquisition of EquityZen but does not establish a connection between the ownership change and the increase.
Platform coverage · Jul 2026
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
closed
Investor
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
EquityZen Securities LLCCRD 281820 on BrokerCheck
New York, NY · Soliciting in all states
Questions About EquityZen Growth Technology Fund LLC - Series 1762
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is EquityZen Growth Technology Fund LLC - Series 1762?
EquityZen Growth Technology Fund LLC - Series 1762 is a Delaware limited liability company that filed a Form D with the SEC on August 1, 2023 as a private equity fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of equity and pooled investment fund interests. AltStreet links the issuer to EquityZen.
Is EquityZen Growth Technology Fund LLC - Series 1762 legit?
AltStreet does not rate legitimacy; it reports the public record. EquityZen Growth Technology Fund LLC - Series 1762 filed a Form D with the SEC on August 1, 2023 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $194,712 sold to 14 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. The issuer is linked to EquityZen, which AltStreet has reviewed. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is EquityZen Growth Technology Fund LLC - Series 1762 registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that EquityZen Growth Technology Fund LLC - Series 1762 claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has EquityZen Growth Technology Fund LLC - Series 1762 raised?
EquityZen Growth Technology Fund LLC - Series 1762 reported $194,712 sold from 14 investors of a $194,712 total offering as of the Form D filed August 1, 2023.
Who can invest in EquityZen Growth Technology Fund LLC - Series 1762?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $10,019.
What is the minimum investment in EquityZen Growth Technology Fund LLC - Series 1762?
The Form D lists $10,019 as the minimum investment accepted from any outside investor as of August 1, 2023. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling EquityZen Growth Technology Fund LLC - Series 1762 and how are they paid?
The Form D names EquityZen Securities LLC (CRD 281820) as the recipient of sales compensation soliciting in all states.
Where is EquityZen Growth Technology Fund LLC - Series 1762 located?
The issuer's address on its SEC filings is 30 Broad St, Suite 1200, New York, NY 10004. Its phone number of record is 1-877-490-6121. It is organized under the laws of Delaware.
How long is the EquityZen Growth Technology Fund LLC - Series 1762 offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
How large is EquityZen Growth Technology Fund LLC - Series 1762?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.